Rituximab May Have Positive Effect on Refractory Nephrotic Syndrome: A Meta-Analysis of Randomized Trials
Open Access
- 30 June 2022
- journal article
- retracted article
- Published by Hindawi Limited in Computational and Mathematical Methods in Medicine
- Vol. 2022, 1-8
- https://doi.org/10.1155/2022/3008597
Abstract
Purpose. This study was aimed at demonstrating the role of rituximab (RTX) on the influence of nephrotic syndrome (NS) and on urinary protein which was not significant. Methods. The clinical randomized controlled trials were performed by eight databases. Meanwhile, the confidence interval (CI) of either relative risk or mean difference was set to 95%. Besides, the heterogeneity of the research results is tested by . Results. A total of 1658 references were found using the search method. This meta-analysis will be done by the ultimately eight different studies. Each study is described as random controlled trial. According to these eight studies, the remission of test group and control group was quite higher (OR: 1.60; 95% Cl: 1.17, 2.20; ) than the control group, serum albumin (SMD: 4.19; 95% Cl: 1.49, 6.89; ), and urine protein (SMD: 0.79; 95% Cl: -0.64, 2.22; ). Despite the fact that the remission...Keywords
This publication has 25 references indexed in Scilit:
- The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines—application to the individual patientKidney International, 2012
- Rituximab in Children with Resistant Idiopathic Nephrotic SyndromeJournal of the American Society of Nephrology, 2012
- Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic SyndromeClinical Journal of the American Society of Nephrology, 2011
- Role of Rituximab Therapy in GlomerulonephritisJournal of the American Society of Nephrology, 2010
- Long-Term Outcome of Biopsy-Proven, Frequently Relapsing Minimal-Change Nephrotic Syndrome in ChildrenClinical Journal of the American Society of Nephrology, 2009
- Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down‐regulation of the T cell costimulatory molecule CD40 ligand: An open‐label trialArthritis & Rheumatism, 2005
- Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective studyClinical Therapeutics, 2004
- The Nonspecificity of Focal Segmental Glomerulosclerosis The Defining Characteristics of Primary Focal Glomerulosclerosis, Mesangial Proliferation, and Minimal ChangeMedicine, 1997
- Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularityKidney International, 1981
- PATHOGENESIS OF LIPOID NEPHROSIS: A DISORDER OF T-CELL FUNCTIONThe Lancet, 1974